Immunological monitoring to prevent and treat sepsis

Critical Care

Volumn 17, Issue 1, 2013, Pages

  Almansa, Raquel ^a   Wain, John ^b   Tamayo, Eduardo ^a   Andaluz Ojeda, David ^a   Martin Loeches, Ignacio ^c   Ramirez, Paula ^d   Bermejo Martin, Jesús F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c HOSPITAL DE SABADELL   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4; HLA DR ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 10;

CYTOKINE RELEASE; DISEASE SEVERITY; HISTOCOMPATIBILITY COMPLEX; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOLOGICAL MONITORING; IMMUNOMODULATION; NATURAL KILLER CELL; NEGATIVE FEEDBACK; NOTE; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; SEPSIS; SEPTIC SHOCK;

EID: 84872834736     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11922     Document Type: Note

References (15)

1. For sepsis, the drugs don't work. Lancet Infect Dis 2012, 12:89. 10.1016/S1473-3099(12)70020-8, 22281132.
2. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010, 36:222-231. 10.1007/s00134-009-1738-3, 2826633, 20069275.
3. Monneret G, Venet F, Kullberg BJ, Netea MG. ICU-acquired immunosuppression and the risk for secondary fungal infections. Med Mycol 2011, 49(Suppl 1):S17-S23.
4. Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M. Immunosuppression following surgical and traumatic injury. Surg Today 2010, 40:793-808. 10.1007/s00595-010-4323-z, 20740341.
5. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008, 14:64-78. 2078557, 18026569.
6. Skrupky LP, Kerby PW, Hotchkiss RS. Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology 2011, 115:1349-1362. 3433833, 21952252.
7. Marchant A, Deviere J, Byl B, De Groote D, Vincent JL, Goldman M. Interleukin-10 production during septicaemia. Lancet 1994, 343:707-708. 10.1016/S0140-6736(94)91584-9, 7907683.
8. Tamayo E, Fernandez A, Almansa R, Carrasco E, Heredia M, Lajo C, Goncalves L, Gomez-Herreras JI, de Lejarazu RO, Bermejo-Martin JF. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw 2011, 22:82-87.
9. Andaluz-Ojeda D, Bobillo F, Iglesias V, Almansa R, Rico L, Gandia F, Resino S, Tamayo E, de Lejarazu RO, Bermejo-Martin JF. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 2012, 57:332-336. 10.1016/j.cyto.2011.12.002, 22197776.
10. Venet F, Gebeile R, Bancel J, Guignant C, Poitevin-Later F, Malcus C, Lepape A, Monneret G. Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol 2011, 11:2086-2090. 10.1016/j.intimp.2011.08.024, 21924385.
11. Andaluz-Ojeda D, Iglesias V, Bobillo F, Almansa R, Rico L, Gandia F, Loma AM, Nieto C, Diego R, Ramos E, Nocito M, Resino S, Eiros JM, Tamayo E, de Lejarazu RO, Bermejo-Martin JF. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 2011, 15:R243. 10.1186/cc10501, 3334794, 22018048.
12. Tamayo E, Fernandez A, Almansa R, Carrasco E, Goncalves L, Heredia M, Andaluz-Ojeda D, March G, Rico L, Gomez-Herreras JI, de Lejarazu RO, Bermejo-Martin JF. Beneficial role of endogenous immunoglobulin subclasses and isotypes in septic shock. J Crit Care 2012, 27:616-622. 10.1016/j.jcrc.2012.08.004, 23089676.
13. Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, Meyer K, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, Shanley TP, . Genomics of Pediatric SIRS/Septic Shock Investigators Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009, 37:1558-1566. 10.1097/CCM.0b013e31819fcc08, 2747356, 19325468, Genomics of Pediatric SIRS/Septic Shock Investigators.
14. Leentjens J, Kox M, Koch RM, Preijers F, Joosten LA, van der Hoeven JG, Netea MG, Pickkers P. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med 2012, 186:838-845. 10.1164/rccm.201204-0645OC, 22822024.
15. Monneret G, Lepape A, Venet F. A dynamic view of mHLA-DR expression in management of severe septic patients. Crit Care 2011, 15:198. 10.1186/cc10452, 3334761, 22011628.